ArticleCancers2025

Survival Benefits of GLP-1 Receptor Agonists in Patients with Neuroendocrine Neoplasms: A Large-Scale Propensity-Matched Cohort Study.

Manal S Fawzy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.